Given the dynamic nature of sPD-L1, in the present study, we examined whether changes in sPD-L1 could correlate with clinical outcomes, including LOS and death, as well as with biochemical and clinical parameters of COVID-19 patients. This evidence concerns the gene SPDL1 and COVID-19.